For the quarter ending 2026-03-31, HCAT made $70,756K in revenue. -$111,026K in net income. Net profit margin of -156.91%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 70,756 | 75,570* | 76,323 | 80,721 |
| Technology | 17,283 | 16,409* | 17,203 | 18,352 |
| Professional Services | 18,010 | 21,573* | 21,304 | 24,128 |
| Total cost of revenue, excluding depreciation and amortization | 35,293 | 37,981* | 38,507 | 42,480 |
| Sales and marketing | 10,585 | 11,127* | 14,361 | 13,206 |
| Research and development | 9,779 | 12,761* | 12,281 | 12,392 |
| General and administrative | 13,960 | 13,030* | 16,069 | 8,284 |
| Depreciation and amortization | 12,115 | 12,553* | 12,614 | 12,684 |
| Impairment of goodwill and intangible assets | - | 67,070* | - | - |
| Impairment of goodwill | 95,501 | - | 0 | 28,769 |
| Total operating expenses | 141,940 | 116,539* | 55,325 | 75,335 |
| Loss from operations | -106,477 | -78,949* | -17,509 | -37,094 |
| Interest and other expense, net | -4,135 | -3,681* | -4,679 | -3,803 |
| Loss before income taxes | -110,612 | -82,630* | -22,188 | -40,897 |
| Income tax provision | 414 | 533* | 41 | 81 |
| Net loss | -111,026 | -83,163 | -22,229 | -40,978 |
| Basic EPS | -1.53 | -1.193 | -0.32 | -0.59 |
| Diluted EPS | -1.53 | -1.193 | -0.32 | -0.59 |
| Basic Average Shares | 72,593,000 | 69,685,460 | 70,377,000 | 69,625,540 |
| Diluted Average Shares | 72,593,000 | 69,685,460 | 70,377,000 | 69,625,540 |
Health Catalyst, Inc. (HCAT)
Health Catalyst, Inc. (HCAT)